Relay Therapeutics RLAY
NASDAQ RLAY
$19.04 +0.03 (+0.16%)
As of: Sep 4, 2026 · 3:59 PM EDT

Relay Therapeutics (RLAY) Property, Plant & Equipment (Net) (2019 - 2026)

Analysis

Relay Therapeutics (RLAY) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Relay Therapeutics 3.87 Bn 3.87 Bn - 862,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 862,000.00
Mar 31, 2026 1.22 Mn
Dec 31, 2025 1.73 Mn
Sep 30, 2025 2.36 Mn
Jun 30, 2025 3.46 Mn
Mar 31, 2025 5.15 Mn
Dec 31, 2024 5.91 Mn
Sep 30, 2024 7.21 Mn
Jun 30, 2024 8.35 Mn
Mar 31, 2024 9.88 Mn
Dec 31, 2023 10.90 Mn
Sep 30, 2023 10.70 Mn
Jun 30, 2023 11.75 Mn
Mar 31, 2023 11.95 Mn
Dec 31, 2022 11.63 Mn
Sep 30, 2022 11.39 Mn
Jun 30, 2022 8.92 Mn
Mar 31, 2022 8.90 Mn
Dec 31, 2021 6.54 Mn
Sep 30, 2021 6.24 Mn